Cargando…
Asthma Patients Benefit More Than Chronic Obstructive Pulmonary Disease Patients in the Coronavirus Disease 2019 Pandemic
Background: Coronavirus disease 2019 (COVID-19) has raised many questions about the role of underlying chronic diseases on disease outcomes. However, there is limited information about the effects of COVID-19 on chronic airway diseases. Therefore, we conducted the present study to investigate the im...
Autores principales: | Xiong, Ruoyan, Zhao, Zhiqi, Lu, Huanhuan, Ma, Yiming, Zeng, Huihui, Chen, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460914/ https://www.ncbi.nlm.nih.gov/pubmed/34568369 http://dx.doi.org/10.3389/fmed.2021.709006 |
Ejemplares similares
-
Nemonoxacin achieved a better symptomatic improvement and a prolonged interval to next exacerbation than moxifloxacin for outpatients with acute exacerbations of chronic obstructive pulmonary disease
por: Meng, Weiwei, et al.
Publicado: (2023) -
Asthma and obstructive sleep apnea: More than an association!
por: Dixit, Ramakant
Publicado: (2018) -
Asthma in patients with suspected and diagnosed coronavirus disease 2019
por: Cao, Lijuan, et al.
Publicado: (2021) -
More Than Meets the Eye: The Similarities Between Coronavirus Disease 2019 and Smoking
por: Lang, Adam Edward, et al.
Publicado: (2020) -
Impact of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap on the prognosis of coronavirus disease 2019
por: Shin, Eunyong, et al.
Publicado: (2022)